Tarek Shazly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tarek Shazly has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Vijaya B. Kolachalama
Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, MA
6 shared publications Alexander Rachev
Biomedical Engineering Program, College of Engineering and Computing, University of South Carolina, Columbia, South Carolina, United States of America
4 shared publications- Mark Jacob Uline
Department of Biomedical Engineering, University of South Carolina, Columbia, SC 29208, USA
4 shared publications - Boran Zhou
Department of Radiology, Mayo Clinic, USA
3 shared publications Francis G. Spinale
3 shared publicationsJahid Ferdous
Department of Biomedical Engineering, Bangladesh University of Engineering and Technology, Dhaka, 1205, Bangladesh
3 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ Kidney360
- Vol.Ā 7 Ā (8) , 1741-1749
Intravascular Ultrasound Is More Accurate Than Angiography in Arteriovenous Vascular Access Lesions
Key Points: Angiography systematically underestimates lumen size in geometrically complex, highly vascular stenotic regions. Intravascular ultrasound maintains accurate, geometry-resilient measurements across stenotic lesions, closely matching computer-aided design ground truth even in lesions with >50% stenosis. Intravascular ultrasound is a more accurate tool for diagnosing and guiding intervention in arteriovenous vascular access dysfunction than angiography. Background: Conventional angiography remains the standard diagnostic modality for arteriovenous (AV) access dysfunction in hemodialysis patients, but its geometric accuracy is limited. Intravascular ultrasound (IVUS) offers superior lesion detection, yet its absolute measurement accuracy remains uncertain. Using three-dimensionalāprinted vascular conduits as reference standards, we assessed the accuracy of IVUS versus angiography, hypothesizing that complex conduit geometry, quantified by Gaussian curvature, would exacerbate angiographic error. Methods: Clinically relevant AV access geometries were modeled with computer-aided design (CAD) and fabricated using three-dimensional printing. Lumen diameters were measured by contrast angiography and IVUS and compared with CAD dimensions. Conduit geometry was characterized using finite elementābased Gaussian curvature mapping. Paired Student t test, Tukey-Kramer correction for multiple testing, and linear mixed-effect modeling were performed to examine the influence of clustering of lesions within conduits. Results: IVUS demonstrated significantly lower measurement error compared with angiography, especially in stenotic segments with >50% luminal narrowing, which persisted even after correction for multiple comparisons ( P < 0.05). These high-grade stenoses frequently coincided with regions of especially high positive or negative Gaussian curvature, reflecting complex conduit geometry. In such regions, angiography consistently underestimated lumen diameter, with error magnitude increasing in curved or tortuous lesions. IVUS measurements closely approximated CAD measurements, retaining accuracy even in severe stenoses. For mild stenoses (<50%) and aneurysmal dilatations, both modalities performed comparably. Conclusions: Geometric complexity directly contributes to modality-specific error. Angiography systematically underestimates lumen dimensions in complex, stenotic regions, while IVUS detects them with higher fidelity and preserves accuracy. These findings establish IVUS as the more reliable modality for evaluating AV access dysfunction and support its integration into routine practice in guiding intervention for AV access stenosis.
- 13 February 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ Kidney360
- Vol.Ā 7 Ā (8) , 1741-1749
Open AccessIntravascular Ultrasound Is More Accurate Than Angiography in Arteriovenous Vascular Access Lesions
Key Points: Angiography systematically underestimates lumen size in geometrically complex, highly vascular stenotic regions. Intravascular ultrasound maintains accurate, geometry-resilient measurements across stenotic lesions, closely matching computer-aided design ground truth even in lesions with >50% stenosis. Intravascular ultrasound is a more accurate tool for diagnosing and guiding intervention in arteriovenous vascular access dysfunction than angiography. Background: Conventional angiography remains the standard diagnostic modality for arteriovenous (AV) access dysfunction in hemodialysis patients, but its geometric accuracy is limited. Intravascular ultrasound (IVUS) offers superior lesion detection, yet its absolute measurement accuracy remains uncertain. Using three-dimensionalāprinted vascular conduits as reference standards, we assessed the accuracy of IVUS versus angiography, hypothesizing that complex conduit geometry, quantified by Gaussian curvature, would exacerbate angiographic error. Methods: Clinically relevant AV access geometries were modeled with computer-aided design (CAD) and fabricated using three-dimensional printing. Lumen diameters were measured by contrast angiography and IVUS and compared with CAD dimensions. Conduit geometry was characterized using finite elementābased Gaussian curvature mapping. Paired Student t test, Tukey-Kramer correction for multiple testing, and linear mixed-effect modeling were performed to examine the influence of clustering of lesions within conduits. Results: IVUS demonstrated significantly lower measurement error compared with angiography, especially in stenotic segments with >50% luminal narrowing, which persisted even after correction for multiple comparisons ( P < 0.05). These high-grade stenoses frequently coincided with regions of especially high positive or negative Gaussian curvature, reflecting complex conduit geometry. In such regions, angiography consistently underestimated lumen diameter, with error magnitude increasing in curved or tortuous lesions. IVUS measurements closely approximated CAD measurements, retaining accuracy even in severe stenoses. For mild stenoses (<50%) and aneurysmal dilatations, both modalities performed comparably. Conclusions: Geometric complexity directly contributes to modality-specific error. Angiography systematically underestimates lumen dimensions in complex, stenotic regions, while IVUS detects them with higher fidelity and preserves accuracy. These findings establish IVUS as the more reliable modality for evaluating AV access dysfunction and support its integration into routine practice in guiding intervention for AV access stenosis.
- 12 January 2026
- Published byĀ American Chemical Society (ACS)Ā inĀ ACS Applied Bio Materials
- Vol.Ā 9 Ā (3) , 1819
Correction to āHydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapyā
- 12 January 2026
- Published byĀ American Chemical Society (ACS)Ā inĀ ACS Applied Bio Materials
- Vol.Ā 9 Ā (3) , 1819
Correction to āHydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapyā
- Open Access
- 9 September 2025
- Published byĀ MDPI AGĀ inĀ Preprints.org
Drug-Coated Balloon Surface Roughness Modulates Intraprocedural Contact Mechanics and Delivery Efficiency: An In-Silico Study
The global prevalence of peripheral artery disease (PAD) continues to rise, driving the increasing clinical use of drug-coated balloons (DCBs). These devices traditionally deliver the antiproliferative drug Paclitaxel (PTX) or its derivatives to the lesion site and have demonstrated superior effectiveness over plain old balloon angioplasty in mitigating post-interventional restenosis. Despite improved clinical outcomes, concerns with inefficient intraprocedural PTX transfer to the arterial wall and resultant off-target/systemic effects remain. This study utilizes DCB-arterial wall structural contact modeling to identify how the microstructural features of urea-based coatings modulate drug transfer efficiency, with consideration of both traditional PTX and recently proposed multi-drug payloads that also deliver the smooth muscle cell relaxant Valsartan (VAL). We incorporated experimentally-obtained measures of coating surface microstructures of PTX-urea and PTX-VAL-urea coatings into finite element models that simulate key physical processes in DCB deployment, namely device-tissue mechanical contact and diffusion-mediated drug transport. Model predictions enable the interrelation of coating surface microstructure to intraprocedural tissue-arterial wall contact area, mechanical load distribution, and drug-specific transfer to the arterial wall. Our findings suggest that coating microstructure modulates the transfer efficiency of PTX but not VAL, which is understood as a consequence of the procedural duration and relative molecular weights/mobilities of these drugs. Taken together, our study underscores the complexity of coating design/dosing for multi-drug payloads and supports the use of computational modeling in the device design process.
- 9 September 2025
- Published byĀ MDPI AGĀ inĀ Preprints.org
Open AccessDrug-Coated Balloon Surface Roughness Modulates Intraprocedural Contact Mechanics and Delivery Efficiency: An In-Silico Study
The global prevalence of peripheral artery disease (PAD) continues to rise, driving the increasing clinical use of drug-coated balloons (DCBs). These devices traditionally deliver the antiproliferative drug Paclitaxel (PTX) or its derivatives to the lesion site and have demonstrated superior effectiveness over plain old balloon angioplasty in mitigating post-interventional restenosis. Despite improved clinical outcomes, concerns with inefficient intraprocedural PTX transfer to the arterial wall and resultant off-target/systemic effects remain. This study utilizes DCB-arterial wall structural contact modeling to identify how the microstructural features of urea-based coatings modulate drug transfer efficiency, with consideration of both traditional PTX and recently proposed multi-drug payloads that also deliver the smooth muscle cell relaxant Valsartan (VAL). We incorporated experimentally-obtained measures of coating surface microstructures of PTX-urea and PTX-VAL-urea coatings into finite element models that simulate key physical processes in DCB deployment, namely device-tissue mechanical contact and diffusion-mediated drug transport. Model predictions enable the interrelation of coating surface microstructure to intraprocedural tissue-arterial wall contact area, mechanical load distribution, and drug-specific transfer to the arterial wall. Our findings suggest that coating microstructure modulates the transfer efficiency of PTX but not VAL, which is understood as a consequence of the procedural duration and relative molecular weights/mobilities of these drugs. Taken together, our study underscores the complexity of coating design/dosing for multi-drug payloads and supports the use of computational modeling in the device design process.
- Open Access
- 25 July 2025
- Published byĀ Springer NatureĀ inĀ Cardiovascular Engineering and Technology
- Vol.Ā 16 Ā (6) , 611-623
Towards the Integration of an Anti-Contractile Compound Within Drug-Coated Balloon Therapy
Purpose: Drug-coated balloon (DCB) therapy is a promising approach to treat peripheral artery disease (PAD), wherein lesion site preparation, balloon inflation, and the local delivery of anti-proliferative drugs such as paclitaxel (PTX) restores and retains lumen patency. Although largely successful in PAD applications, broader clinical deployment is in part limited by the occurrence of late lumen loss due to inward vessel remodeling at the treatment site, a maladaptive chronic response that has been clinically-observed to coincide with elevations in resident vascular smooth muscle cell (vSMC) tone. This study aims to explore a novel strategy to improve DCB efficacy via drug-based attenuation of vSMC tone at the treatment site. Methods: As a strategy to mitigate this post-DCB failure mode, we consider the local co-delivery of PTX and an additional drug that induces relaxation of vSMCs, specifically the clinically-approved anti-hypertensive drug valsartan (VAL). The potential benefit of drug-based regulation of vSMC tone is supported by recent theoretical studies that predict inward remodeling in the presence of hypertension and endothelial cell dysfunction, both common co-morbidities in PAD patients and established causes of elevated vSMC contractility. The specific selection of VAL as the anti-contractile payload constituent is motivated by its well-known pharmacokinetic and safety profiles, and the notion that current clinical use and familiarity could promote rapid translation in the context of DCBs. Results: Our obtained results quantify the potency of VAL to induce local vSMC relaxation in arterial tissue, demonstrate the feasibility of PTX and VAL co-delivery using the canonical excipient urea for balloon coating formation, and elucidate key structure-function relations to facilitate efficient drug delivery with these novel coatings. Conclusion: Our study supports the continued evaluation of VAL for inclusion in DCB formulations due to its potential to redirect post-treatment arterial remodeling. Future in-vivo studies which examine the co-delivery of PTX and VAL in the context of DCBs are needed to establish both the safety and efficacy of this novel approach.
- 25 July 2025
- Published byĀ Springer NatureĀ inĀ Cardiovascular Engineering and Technology
- Vol.Ā 16 Ā (6) , 611-623
Open AccessTowards the Integration of an Anti-Contractile Compound Within Drug-Coated Balloon Therapy
Purpose: Drug-coated balloon (DCB) therapy is a promising approach to treat peripheral artery disease (PAD), wherein lesion site preparation, balloon inflation, and the local delivery of anti-proliferative drugs such as paclitaxel (PTX) restores and retains lumen patency. Although largely successful in PAD applications, broader clinical deployment is in part limited by the occurrence of late lumen loss due to inward vessel remodeling at the treatment site, a maladaptive chronic response that has been clinically-observed to coincide with elevations in resident vascular smooth muscle cell (vSMC) tone. This study aims to explore a novel strategy to improve DCB efficacy via drug-based attenuation of vSMC tone at the treatment site. Methods: As a strategy to mitigate this post-DCB failure mode, we consider the local co-delivery of PTX and an additional drug that induces relaxation of vSMCs, specifically the clinically-approved anti-hypertensive drug valsartan (VAL). The potential benefit of drug-based regulation of vSMC tone is supported by recent theoretical studies that predict inward remodeling in the presence of hypertension and endothelial cell dysfunction, both common co-morbidities in PAD patients and established causes of elevated vSMC contractility. The specific selection of VAL as the anti-contractile payload constituent is motivated by its well-known pharmacokinetic and safety profiles, and the notion that current clinical use and familiarity could promote rapid translation in the context of DCBs. Results: Our obtained results quantify the potency of VAL to induce local vSMC relaxation in arterial tissue, demonstrate the feasibility of PTX and VAL co-delivery using the canonical excipient urea for balloon coating formation, and elucidate key structure-function relations to facilitate efficient drug delivery with these novel coatings. Conclusion: Our study supports the continued evaluation of VAL for inclusion in DCB formulations due to its potential to redirect post-treatment arterial remodeling. Future in-vivo studies which examine the co-delivery of PTX and VAL in the context of DCBs are needed to establish both the safety and efficacy of this novel approach.
- 11 October 2024
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 147 Ā (1) , 1-17
Image-Based Estimation of Left Ventricular Myocardial Stiffness
Elevation in left ventricular (LV) myocardial stiffness is a key remodeling-mediated change that underlies the development and progression of heart failure (HF). Despite the potential diagnostic value of quantifying this deterministic change, there is a lack of enabling techniques that can be readily incorporated into current clinical practice. To address this unmet clinical need, we propose a simple protocol for processing routine echocardiographic imaging data to provide an index of left ventricular myocardial stiffness, with protocol specification for patients at risk for heart failure with preserved ejection fraction. We demonstrate our protocol in both a preclinical and clinical setting, with representative findings that suggest sensitivity and translational feasibility of obtained estimates.
- 11 October 2024
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 147 Ā (1) , 1-17
Image-Based Estimation of Left Ventricular Myocardial Stiffness
Elevation in left ventricular (LV) myocardial stiffness is a key remodeling-mediated change that underlies the development and progression of heart failure (HF). Despite the potential diagnostic value of quantifying this deterministic change, there is a lack of enabling techniques that can be readily incorporated into current clinical practice. To address this unmet clinical need, we propose a simple protocol for processing routine echocardiographic imaging data to provide an index of left ventricular myocardial stiffness, with protocol specification for patients at risk for heart failure with preserved ejection fraction. We demonstrate our protocol in both a preclinical and clinical setting, with representative findings that suggest sensitivity and translational feasibility of obtained estimates.
- 25 April 2024
- Published byĀ American Chemical Society (ACS)Ā inĀ ACS Applied Bio Materials
- Vol.Ā 7 Ā (5) , 3041-3049
Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy
Drug-coated balloon (DCB) therapy is a promising endovascular treatment for obstructive arterial disease. The goal of DCB therapy is restoration of lumen patency in a stenotic vessel, whereby balloon deployment both mechanically compresses the offending lesion and locally delivers an antiproliferative drug, most commonly paclitaxel (PTX) or derivative compounds, to the arterial wall. Favorable long-term outcomes of DCB therapy thus require predictable and adequate PTX delivery, a process facilitated by coating excipients that promotes rapid drug transfer during the inflation period. While a variety of excipients have been considered in DCB design, there is a lack of understanding about the coating-specific biophysical determinants of essential device function, namely, acute drug transfer. We consider two hydrophilic excipients for PTX delivery, urea (UR) and poly(ethylene glycol) (PEG), and examine how compositional and preparational variables in the balloon surface spray-coating process impact resultant coating microstructure and in turn acute PTX transfer to the arterial wall. Specifically, we use scanning electron image analyses to quantify how coating microstructure is altered by excipient solid content and balloon-to-nozzle spray distance during the coating procedure and correlate obtained microstructural descriptors of coating aggregation to the efficiency of acute PTX transfer in a one-dimensional ex vivo model of DCB deployment. Experimental results suggest that despite the qualitatively different coating surface microstructures and apparent PTX transfer mechanisms exhibited with these excipients, the drug delivery efficiency is generally enhanced by coating aggregation on the balloon surface. We illustrate this microstructure-function relation with a finite element-based computational model of DCB deployment, which along with our experimental findings suggests a general design principle to increase drug delivery efficiency across a broad range of DCB designs.
- 25 April 2024
- Published byĀ American Chemical Society (ACS)Ā inĀ ACS Applied Bio Materials
- Vol.Ā 7 Ā (5) , 3041-3049
Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy
Drug-coated balloon (DCB) therapy is a promising endovascular treatment for obstructive arterial disease. The goal of DCB therapy is restoration of lumen patency in a stenotic vessel, whereby balloon deployment both mechanically compresses the offending lesion and locally delivers an antiproliferative drug, most commonly paclitaxel (PTX) or derivative compounds, to the arterial wall. Favorable long-term outcomes of DCB therapy thus require predictable and adequate PTX delivery, a process facilitated by coating excipients that promotes rapid drug transfer during the inflation period. While a variety of excipients have been considered in DCB design, there is a lack of understanding about the coating-specific biophysical determinants of essential device function, namely, acute drug transfer. We consider two hydrophilic excipients for PTX delivery, urea (UR) and poly(ethylene glycol) (PEG), and examine how compositional and preparational variables in the balloon surface spray-coating process impact resultant coating microstructure and in turn acute PTX transfer to the arterial wall. Specifically, we use scanning electron image analyses to quantify how coating microstructure is altered by excipient solid content and balloon-to-nozzle spray distance during the coating procedure and correlate obtained microstructural descriptors of coating aggregation to the efficiency of acute PTX transfer in a one-dimensional ex vivo model of DCB deployment. Experimental results suggest that despite the qualitatively different coating surface microstructures and apparent PTX transfer mechanisms exhibited with these excipients, the drug delivery efficiency is generally enhanced by coating aggregation on the balloon surface. We illustrate this microstructure-function relation with a finite element-based computational model of DCB deployment, which along with our experimental findings suggests a general design principle to increase drug delivery efficiency across a broad range of DCB designs.
- 4 September 2023
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 145 Ā (12) , 1-48
Novel Payloads to Mitigate Maladaptive Inward Arterial Remodeling in Drug-Coated Balloon Therapy
Drug-coated balloon therapy is a minimally invasive endovascular approach to treat obstructive arterial disease, with increasing utilization in the peripheral circulation due to improved outcomes as compared to alternative interventional modalities. Broader clinical use of drug-coated balloons is limited by an incomplete understanding of device- and patient-specific determinants of treatment efficacy, including late outcomes that are mediated by postinterventional maladaptive inward arterial remodeling. To address this knowledge gap, we propose a predictive mathematical model of pressure-mediated femoral artery remodeling following drug-coated balloon deployment, with account of drug-based modulation of resident vascular cell phenotype and common patient comorbidities, namely, hypertension and endothelial cell dysfunction. Our results elucidate how postinterventional arterial remodeling outcomes are altered by the delivery of a traditional anti-proliferative drug, as well as by codelivery with an anti-contractile drug. Our findings suggest that codelivery of anti-proliferative and anti-contractile drugs could improve patient outcomes following drug-coated balloon therapy, motivating further consideration of novel payloads in next-generation devices.
- 4 September 2023
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 145 Ā (12) , 1-48
Novel Payloads to Mitigate Maladaptive Inward Arterial Remodeling in Drug-Coated Balloon Therapy
Drug-coated balloon therapy is a minimally invasive endovascular approach to treat obstructive arterial disease, with increasing utilization in the peripheral circulation due to improved outcomes as compared to alternative interventional modalities. Broader clinical use of drug-coated balloons is limited by an incomplete understanding of device- and patient-specific determinants of treatment efficacy, including late outcomes that are mediated by postinterventional maladaptive inward arterial remodeling. To address this knowledge gap, we propose a predictive mathematical model of pressure-mediated femoral artery remodeling following drug-coated balloon deployment, with account of drug-based modulation of resident vascular cell phenotype and common patient comorbidities, namely, hypertension and endothelial cell dysfunction. Our results elucidate how postinterventional arterial remodeling outcomes are altered by the delivery of a traditional anti-proliferative drug, as well as by codelivery with an anti-contractile drug. Our findings suggest that codelivery of anti-proliferative and anti-contractile drugs could improve patient outcomes following drug-coated balloon therapy, motivating further consideration of novel payloads in next-generation devices.
- Open Access
- 1 September 2022
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 145 Ā (1)
A Mathematical Model of Maladaptive Inward Eutrophic Remodeling of Muscular Arteries in Hypertension
We propose a relatively simple two-dimensional mathematical model for maladaptive inward remodeling of resistive arteries in hypertension in terms of vascular solid mechanics. The main premises are: (i) maladaptive inward remodeling manifests as a reduced increase in the arterial mass compared to the case of adaptive remodeling under equivalent hypertensive pressures and (ii) the pressure-induced circumferential stress in the arterial wall is restored to its basal target value as happens in the case of adaptive remodeling. The rationale for these assumptions is the experimental findings that elevated tone in association with sustained hypertensive pressure down-regulate the normal differentiation of vascular smooth muscle cells from contractile to synthetic phenotype and the data for the calculated hoop stress before and after completion of remodeling. Results from illustrative simulations show that as the hypertensive pressure increases, remodeling causes a nonmonotonic variation of arterial mass, a decrease in inner arterial diameter, and an increase in wall thickness. These findings and the model prediction that inward eutrophic remodeling is preceded by inward hypertrophic remodeling are supported by published observations. Limitations and perspectives for refining the mathematical model are discussed.
- 1 September 2022
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 145 Ā (1)
Open AccessA Mathematical Model of Maladaptive Inward Eutrophic Remodeling of Muscular Arteries in Hypertension
We propose a relatively simple two-dimensional mathematical model for maladaptive inward remodeling of resistive arteries in hypertension in terms of vascular solid mechanics. The main premises are: (i) maladaptive inward remodeling manifests as a reduced increase in the arterial mass compared to the case of adaptive remodeling under equivalent hypertensive pressures and (ii) the pressure-induced circumferential stress in the arterial wall is restored to its basal target value as happens in the case of adaptive remodeling. The rationale for these assumptions is the experimental findings that elevated tone in association with sustained hypertensive pressure down-regulate the normal differentiation of vascular smooth muscle cells from contractile to synthetic phenotype and the data for the calculated hoop stress before and after completion of remodeling. Results from illustrative simulations show that as the hypertensive pressure increases, remodeling causes a nonmonotonic variation of arterial mass, a decrease in inner arterial diameter, and an increase in wall thickness. These findings and the model prediction that inward eutrophic remodeling is preceded by inward hypertrophic remodeling are supported by published observations. Limitations and perspectives for refining the mathematical model are discussed.
- 12 December 2019
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 142 Ā (4)
A Two-Dimensional Model of Hypertension-Induced Arterial Remodeling With Account for Stress Interaction Between Elastin and Collagen
We propose a novel structure-based two-dimensional (2D) mathematical model of hypertension-induced arterial remodeling. The model is built in the framework of the constrained mixture theory and global growth approach, utilizing a recently proposed structure-based constitutive model of arterial tissue that accounts for the individual natural configurations of and stress interaction between elastin and collagen. The basic novel predictive result is that provided remodeling causes a change in the elastin/collagen mass fraction ratio, it leads to a structural reorganization of collagen that manifests as an altered fiber undulation and a change in direction of the helically oriented fibers in the tissue natural state. Results obtained from the illustrative simulations for a porcine renal artery show that when remodeling is complete the collagen reorganization might have significant effects on the initial arterial geometry and mechanical properties of the arterial tissue. The proposed model has potential to describe and advance mechanistic understanding of adaptive arterial remodeling, promote the continual refinement of mathematical models of arterial remodeling, and provide motivation for new avenues of experimental investigation.
- 12 December 2019
- Published byĀ ASME InternationalĀ inĀ Journal of Biomechanical Engineering
- Vol.Ā 142 Ā (4)
A Two-Dimensional Model of Hypertension-Induced Arterial Remodeling With Account for Stress Interaction Between Elastin and Collagen
We propose a novel structure-based two-dimensional (2D) mathematical model of hypertension-induced arterial remodeling. The model is built in the framework of the constrained mixture theory and global growth approach, utilizing a recently proposed structure-based constitutive model of arterial tissue that accounts for the individual natural configurations of and stress interaction between elastin and collagen. The basic novel predictive result is that provided remodeling causes a change in the elastin/collagen mass fraction ratio, it leads to a structural reorganization of collagen that manifests as an altered fiber undulation and a change in direction of the helically oriented fibers in the tissue natural state. Results obtained from the illustrative simulations for a porcine renal artery show that when remodeling is complete the collagen reorganization might have significant effects on the initial arterial geometry and mechanical properties of the arterial tissue. The proposed model has potential to describe and advance mechanistic understanding of adaptive arterial remodeling, promote the continual refinement of mathematical models of arterial remodeling, and provide motivation for new avenues of experimental investigation.
- Open Access
- 5 February 2018
- Published byĀ Public Library of Science (PLoS)Ā inĀ PLOS ONE
- Vol.Ā 13 Ā (2) , e0192032
Mechanical and geometrical determinants of wall stress in abdominal aortic aneurysms: A computational study
An aortic aneurysm (AA) is a focal dilatation of the aortic wall. Occurrence of AA rupture is an all too common event that is associated with high levels of patient morbidity and mortality. The decision to surgically intervene prior to AA rupture is made with recognition of significant procedural risks, and is primarily based on the maximal diameter and/or growth rate of the AA. Despite established thresholds for intervention, rupture occurs in a notable subset of patients exhibiting sub-critical maximal diameters and/or growth rates. Therefore, a pressing need remains to identify better predictors of rupture risk and ultimately integrate their measurement into clinical decision making. In this study, we use a series of finite element-based computational models that represent a range of plausible AA scenarios, and evaluate the relative sensitivity of wall stress to geometrical and mechanical properties of the aneurysmal tissue. Taken together, our findings encourage an expansion of geometrical parameters considered for rupture risk assessment, and provide perspective on the degree to which tissue mechanical properties may modulate peak stress values within aneurysmal tissue.
- 5 February 2018
- Published byĀ Public Library of Science (PLoS)Ā inĀ PLOS ONE
- Vol.Ā 13 Ā (2) , e0192032
Open AccessMechanical and geometrical determinants of wall stress in abdominal aortic aneurysms: A computational study
An aortic aneurysm (AA) is a focal dilatation of the aortic wall. Occurrence of AA rupture is an all too common event that is associated with high levels of patient morbidity and mortality. The decision to surgically intervene prior to AA rupture is made with recognition of significant procedural risks, and is primarily based on the maximal diameter and/or growth rate of the AA. Despite established thresholds for intervention, rupture occurs in a notable subset of patients exhibiting sub-critical maximal diameters and/or growth rates. Therefore, a pressing need remains to identify better predictors of rupture risk and ultimately integrate their measurement into clinical decision making. In this study, we use a series of finite element-based computational models that represent a range of plausible AA scenarios, and evaluate the relative sensitivity of wall stress to geometrical and mechanical properties of the aneurysmal tissue. Taken together, our findings encourage an expansion of geometrical parameters considered for rupture risk assessment, and provide perspective on the degree to which tissue mechanical properties may modulate peak stress values within aneurysmal tissue.